Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

BusinessWeek April 18, 2005 Manjeet Kripalani	India: Bigger Pharma Tougher patent protection laws are spurring rapid growth in new drug research across India.
BusinessWeek January 12, 2004 Manjeet Kripalani	India: Big Pharma's New Promised Land? Drugmakers are heeding the siren call of its well-trained, cheap chemists.
Chemistry World February 13, 2012	Building a nation of scientists Goverdhan Mehta talks to Sheena Elliott and Elinor Richards about the progress of science in India and the challenges scientists face
Chemistry World August 21, 2006 Killugudi Jayaraman	Indian Research Institutes Face Tough Times A growing crisis in academic recruitment at the Indian Institutes of Technology is threatening to disrupt teaching and research, and could put international collaborations in jeopardy.
Chemistry World March 25, 2008 Killugudi Jayaraman	Chemistry's 'Colossal' Fraud One of the biggest cases of scientific fraud in chemistry is continuing to send shockwaves across India, as concerns are raised over the senior academics who co-authored multiple academic papers with researcher Pattium Chiranjeevi.
Chemistry World October 8, 2010 Akshat Rathi	India calls for ambitious increase in science funding The Scientific Advisory Council to the Prime Minister of India has advised the government to increase its science funding from less than 1 per cent of GDP to up to 2.5 per cent by 2020.
Chemistry World September 5, 2014 Dinsa Sachan	Tussle over four-year science degrees in India India's higher education watchdog, the University Grants Commission, is clamping down on four-year undergraduate courses in the country in a move that has affected many science degrees.
Chemistry World March 6, 2015 Sanjay Kumar	Scientists left unimpressed by Indian budget The Indian government's 'big-bang' budget has left the country's science community sorely disappointed.
Chemistry World February 15, 2007 Victoria Gill	Novartis Contests India's Patent Law Swiss pharmaceutical company Novartis has accused the Indian government of failing to comply with WTO rules after it refused to grant the company a patent on its cancer drug Glivec.
Chemistry World December 18, 2015 Ned Stafford	India maintains scientific edge despite static funding Researchers in India are increasingly authoring articles published in 'high-quality scientific publications' despite continued stagnation in Indian government spending for research, according to a new Nature Index analytics report.
Chemistry World August 6, 2007 Victoria Gill	Novartis Loses Indian Patent Law Case Swiss drug firm Novartis has lost its legal case against the Indian government, who it had accused of 'unconstitutional' patent law practices. The ruling sets an important precedent that will cheer the flourishing generics market in the country.
Chemistry World March 20, 2012 Rajesh Parishwad	India Green Lights Production of Patented Cancer Drug For the first time India has invoked a 'compulsory license' clause to cut the cost of a patented anti-cancer drug by allowing another company to manufacture the therapy.
Chemistry World April 20, 2007 Killugudi Jayaraman	Pesticide Filter Debuts in India A domestic water filter that uses metal nanoparticles to remove dissolved pesticide residues is about to enter the Indian market. Its developers believe it is the first product of its kind in the world to be commercialized.
Chemistry World August 29, 2007 Killugudi Jayaraman	India Announces Plans for Its First Nanopark Already the home for India's leading software and biotech firms, Bangalore is now aiming to attract businesses in another emerging area: nanotechnology.
HHMI Bulletin Nov 2011 Sarah C.P. Williams.	Carolyn Bertozzi: Changed Expectations Chemists trained in biology were once a rarity -- now they're becoming the norm.
Chemistry World January 5, 2007 Victoria Gill	PEG Makes Cheaper Drugs for Developing Countries UK and Indian scientists have embarked on a collaboration to develop a new protein-based treatment for hepatitis C, which they say will provide an affordable drug urgently needed in countries where resources are limited.
Chemistry World September 17, 2007	US Reforms Could Double the Cost of Chemistry Patents The US House of Representatives approved legislation last week that could dramatically raise the cost of patenting chemical reactions and discourage researchers from presenting or publishing their work.
Chemistry World September 17, 2010 Andrew Turley	Free trade could throttle generics from India International agreements on intellectual property threaten the flow of generic HIV drugs from India to developing countries, according to a new report.
The Motley Fool March 28, 2005 Brian Gorman	A Passage to India? Changes in India's patent law could create new dynamics for the biotech and pharmaceutical industries. Investors should be on the lookout for the firms that seek to leverage these new opportunities.
Chemistry World February 20, 2013 Laura Howes	UK-India projects launched To coincide with the prime minister's visit to India, UK universities have announced a series of research partnerships and scholarships intended to boost the trade and education links between the UK and India.
Pharmaceutical Executive October 1, 2011 Amrita Ghaswalla	Changing the Dialogue No industry leader is more closely associated with the goal of seeding the globe with low-cost generics than Mumbai-based Cipla Chairman Y.K. Hamied.
Chemistry World December 8, 2011 Sarah Houlton	Academia Grows Its Role in Drug Discovery The number of pharma patents being filed by universities around the world is soaring compared with those coming from industry.
Chemistry World February 12, 2015 Rajesh Parishwad	Fertilizing India's petrochemical industry Indian minister for chemicals and fertilizers H N Ananth Kumar is confident that India will be an important global player in the petrochemical sector.
Chemistry World January 10, 2012 Rajesh Parishwad	Indian science needs to raise its game Despite a three-fold increase in public R&D in the last five years, Indian science and research is yet to make a significant impact on the global scene according to Indian Prime Minister Manmohan Singh.
BusinessWeek November 20, 2008 David Rocks	India's Design Boom Offshore and domestic customers seek an edge to satisfy India's consumers, who have more money to spend and are demanding better products
Reactive Reports Issue 55 David Bradley	Interview with Wendy Warr This well-known and well-respected expert in the field of chemical information creates online reports and opinions that are essential reading for chemists hoping to understand the changes in information that are currently underway.
BusinessWeek October 10, 2005 Manjeet Kripalani	India: A Quiet Shopping Spree So far, foreign companies being bought by Indian players are small - but that's likely to change
BusinessWeek February 27, 2006 Einhorn & Kripalani	In India, Selling Generics Used To Be So Easy Suddenly, Indian drugmakers Dr. Reddy's and Ranbaxy have a host of copycat rivals.
Chemistry World October 17, 2014 Dinsa Sachan	Indian manufacturers hit back over quality claims The Indian pharmaceutical industry has asked its government to sue authors of a study published by the US National Bureau of Economic Research in early September.
Chemistry World April 8, 2013 Sarah Houlton	India rejects Novartis patent appeal India's Supreme Court has denied Novartis' appeal against the decision to refuse patent protection for its anticancer drug Glivec (imatinib mesylate).
Chemistry World July 6, 2012	Protein power Tom Muir, professor of chemistry and molecular biology, Princeton University, US, is an expert in protein engineering and its application to studying cellular signalling networks.
Pharmaceutical Executive April 1, 2014 Subramanian et al.	"Market-Based" Price Controls In India? Three strategic implications for pharma pricing strategies in India.
Chemistry World February 12, 2015 S Umapathy	Indian science at the crossroads How should Indian scientific research evolve?
Chemistry World February 3, 2015 Sanjay Kumar	India's chemistry challenges While India is yet to catch up with the global cutting edge technologies, some of its interventions have made global headlines.
IndustryWeek February 1, 2004 Traci Purdum	GM Taps India For IT And R&D The leading automaker invests $21 million to set up shop in Bangalore.
Chemistry World September 3, 2014 Rajesh Parishwad	Piramal exits drug discovery in India India's Piramal Enterprises is exiting its early-stage drug discovery research and focusing on late clinical development, along with its core areas such as generics and contract research services.
Global Services June 10, 2008 Shyamanuja Das	Outsourcing to India: 1998 Vs. 2008 If you want to offshore to India for the same reasons some of your peers did in 1998, then do so at your own risk.
InternetNews December 6, 2005 Colin C. Haley	Microsoft Plans 30 New R&D Centers Microsoft Chairman Bill Gates kicked off a four-day India trip by outlining a plan to build 30 new innovation centers around the world, including one in the tech-heavy Indian city of Bangalore.
Chemistry World July 2008 Kevin Rogers	What future for small molecule therapy? Pharmaceutical companies overlook bench chemists at their peril
CIO December 1, 2000 Tom Field	The Learning Channel India has developed a global reputation for producing the best and brightest IT minds. What's its secret?
Chemistry World July 14, 2014 Richa Malhotra	Indian scientists applaud research budget The newly-elected Indian government laid out its plans for the country in its 2014 -- 15 budget last week and research has fared reasonably well.
BusinessWeek September 3, 2007 Manjeet Kripalani	A Red-Hot Big Blue In India From inking deals to hiring the best workers, IBM is leading its tech services rivals in India.
Chemistry World March 6, 2013 Jon Evans	Data challenges for UK chemists Academic chemists in the UK have a problem with data. That's the claim made by a report that says that both in terms of managing and sharing data produced by their own laboratories and accessing data produced by others, chemists are all at sea.
Salon.com January 4, 2002 Jeffrey Benner	Public money, private code The drive to license academic research for profit is stifling the spread of software that could be of universal benefit...
The Motley Fool June 5, 2006 Stephen D. Simpson	Reddy More Steady? Despite sharp sell-offs in India, Dr. Reddy's is still improving. As is often the case with turnarounds, the Indian pharmaceutical doesn't look especially cheap today.
Chemistry World September 2008 Derek Lowe	Column: In the pipeline The author remembers leaving the ivory towers of academe to trade 'unusual and beautiful' for 'useful'
InternetNews December 5, 2005 Colin C. Haley	Intel India Earmarks $1B For India Intel will invest more than $1 billion in India over the next five years to increase its presence in a country that continues to evolve into an economic powerhouse. The chipmaker's five-year plan includes R&D and VC investment.
IEEE Spectrum March 2006 Seema Singh	Big Players in Chip Design Buy Into India India's position suddenly seems so strong in both market potential and engineering resources that it could soon be driving some of the major global developments in chip design.
The Motley Fool July 10, 2007 Sham Gad	HDFC Vaults Skyward The Indian bank is growing and poised to get even bigger. Investors, take note.
The Motley Fool March 31, 2010 Brian Orelli	When One Patent Means So Much The loss of patents on genes could have far-reaching consequences for drug companies.